Net Asset Value(s)
Summary by AI BETAClose X
On 05-Nov-26 Invesco NASDAQ Biotech UCITS ETF (ticker SBIO) reported a net asset value per share of USD 73.8971 with 7,966,396 shares outstanding, implying total net assets of approximately USD 588,693,562; the RNS release is a routine NAV publication and contains no additional operational guidance or manager commentary that would alter the fund's publicly disclosed valuation.
IVZ Nasdaq Biotech UCITS ETF$
06 November 2026
|
FUND: |
Invesco NASDAQ Biotech UCITS ETF |
|
DEALING DATE: |
05-Nov-26 |
|
NAV PER SHARE: |
USD:73.8971 |
|
NUMBER OF SHARES IN ISSUE: |
7,966,396.00 |
|
CODE: |
SBIO |
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 hours ago Oxford Nanopore Technologies
- 3 hours ago AVI Global Trust
- 4 hours ago LSL Property Services
- 4 hours ago Bluebird Merchant Ventures (DI)
- 4 hours ago Power Probe PLC